Institutional Ownership Brainstorm Cell Therapeutics Inc. (BCLI)
This table provides information about the institutional ownership of Brainstorm Cell Therapeutics Inc. (BCLI). We have compiled data on the 5 institutions that hold shares in the stock, with a total of 500,353 shares, which have been reported (via 13F filing form) to have a value of $640,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
386,414
shares
|
$494,609
0.0% of portfolio
|
Q2 2024
Reduced 21.03%
|
|
|
Raymond James & Associates
St Petersburg, FL |
Oct 18, 2024 Q3 2024 |
95,153
shares
|
$121,795
0.0% of portfolio
|
Q3 2024
Reduced 14.5%
|
|
|
S.C. Financial Services, Inc.
|
Jan 19, 2023 Q4 2022 |
12,686
shares
|
$16,238
0.03% of portfolio
|
Q4 2022
New holding
|
|
|
Institutional & Family Asset Management, LLC
|
Jul 05, 2024 Q2 2024 |
6,000
shares
|
$7,680
0.0% of portfolio
|
Q3 2023
Added 100.0%
|
|
|
Piershale Financial Group, Inc.
|
Jul 06, 2023 Q2 2023 |
100
shares
|
$128
0.0% of portfolio
|
Q1 2023
New holding
|